Overview

AbbVie is a global biopharmaceutical company headquartered in North Chicago, Illinois, formed in 2013 as a spin-off from Abbott Laboratories. The company specializes in immunology, oncology, and neuroscience, with a focus on peptide-based therapeutics and biologics.

Peptide Therapeutics

AbbVie’s peptide portfolio includes leuprolide acetate (Lupron), a synthetic GnRH agonist used for prostate cancer, endometriosis, and precocious puberty. The company also develops peptide drug conjugates and novel peptide formulations for targeted delivery.

Research Focus

AbbVie’s research pipeline includes peptide-based approaches for autoimmune diseases, cancer immunotherapy, and neurological disorders. The company invests in computational peptide design and advanced delivery systems to improve therapeutic efficacy.

Applications

AbbVie has been studied for its potential applications in:

• Biomedical research
• Drug discovery
• Diagnostic applications
• Therapeutic development

References

• Source: peptide-patents.md
• Database: Wikipept Peptide Database